Enveric Biosciences (ENVB) Research & Development (2020 - 2026)
Enveric Biosciences (ENVB) posted Research & Development of $1.36 million for Q2 2026, up 7.5% from $1.26 million a year earlier and up 291.7% from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) Research & Development (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Enveric Biosciences was $2.48 million, down 34.4% year-over-year; for FY2025, it came in at $2.78 million, down 2.1% from FY2024.
- Annual Research & Development has declined for three consecutive years, though with a five-year compound annual growth rate of 74.1% (FY2020 to FY2025).
- In prior years, Enveric Biosciences' Research & Development was $2.84 million in FY2024 (-60.8%), $7.25 million in FY2023 (-9.7%), $8.03 million in FY2022 (+67.6%) and $4.79 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Research & Development since Q4 2023.
- On a year-over-year basis, Research & Development increased in three of the last eight quarters, with an average decline of 8.5%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q2 2022, with growth of 141.0%; the weakest was Q2 2024, with a decline of 76.4%.
- According to Business Quant data, Research & Development for the three prior quarters was $345,969 (Q1 2026), $372,178 (Q4 2025) and $402,417 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Enveric Biosciences | 5.86 Mn | -15.78 Mn | - | 1.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.36 Mn |
| Mar 31, 2026 | 345,969.00 |
| Dec 31, 2025 | 372,178.00 |
| Sep 30, 2025 | 402,417.00 |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 746,371.00 |
| Dec 31, 2024 | 967,399.00 |
| Sep 30, 2024 | 802,717.00 |
| Jun 30, 2024 | 565,001.00 |
| Mar 31, 2024 | 506,155.00 |
| Dec 31, 2023 | 1.72 Mn |
| Sep 30, 2023 | 1.28 Mn |
| Jun 30, 2023 | 2.40 Mn |
| Mar 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 2.06 Mn |
| Jun 30, 2022 | 2.12 Mn |
| Mar 31, 2022 | 1.96 Mn |
| Dec 31, 2021 | 2.49 Mn |
| Sep 30, 2021 | 1.22 Mn |
API Access
Enveric Biosciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();